Immunize

Serotype B Meningococcal Vaccine

search

Serotype B Meningococcal Vaccine, Meningococcal Serogroup B, Trumenba, MenB-FHbp, Bexsero, MenB-4C

  • See Also
  1. Meningococcal Vaccine (Menactra, Menveo, MCV4)
  2. Menomune (MPSV4)
  3. Neisseria Meningitidis
  4. Bacterial Meningitis
  • Indications (age 10 years old or older)
  1. Serotype B Meningococcal Meningitis exposure
  2. Asplenia
  3. Sickle Cell Disease
  4. Specific immune deficiency
  • Mechanism
  1. Covers only Serotype B Meningococcus
    1. Accounts for one third of meningococcal cases
    2. Serotype B outbreaks are most common in infants and college students
  2. Contrast with Menactra, Menveo and Menomune which cover serotypes A, C, W and Y
    1. Indicated for all U.S. children as part of the Primary Series
  • Preparations (FDA approved in 2014)
  1. Must use same preparation for both doses (not interchangeable)
  2. MenB-FHbp (Trumenba)
    1. Two dose regimen at least 6 months apart (0 and 6 months)
      1. Two dose regimen may be used for healthy patients ages 16-23 years AND
      2. Not at increased meningococcal disease
    2. Three dose series (0, 2 and 6 months)
      1. Indicated for Asplenia, complement deficiency, or complement inhibitor
  3. MenB-4C (Bexsero)
    1. Two dose series at least 1 month apart (0 and 1-6 months)
  • Resources
  1. CDC Immunization Schedules (last accessed 10/28/2020)
    1. https://www.cdc.gov/vaccines/hcp/imz-schedules/index.html
  • References
  1. Jacobson (2017) Vaccine Update,Mayo Clinic Reviews, Rochester, MN
  2. (2015) Presc Lett 22(10): 59
  3. Ackerman (2015) Am Fam Physician 92(6): 460-8 [PubMed]
  4. Cohn (2013) MMWR Recomm Rep 62(RR-2):1-28 [PubMed]